Evidence map›Paper›PMID 26091717›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Membrane Type 1 Matrix Metalloproteinase Regulates Monocyte Migration and Collagen Destruction in Tuberculosis.

Tarangini Sathyamoorthy, Liku B Tezera, Naomi F Walker, Sara Brilha, Luisa Saraiva, Francesco A Mauri, Robert J Wilkinson, Jon S Friedland, Paul T Elkington

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. eLife · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.American journal of respiratory and critical care medicine · 2018
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Tarangini SathyamoorthyInfectious Diseases and Immunity, Imperial College London, London W12 0NN, United Kingdom;
Liku B TezeraNational Institute for Health Research Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Naomi F WalkerInfectious Diseases and Immunity, Imperial College London, London W12 0NN, United Kingdom; Clinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa;
Sara BrilhaInfectious Diseases and Immunity, Imperial College London, London W12 0NN, United Kingdom;
Luisa SaraivaInfectious Diseases and Immunity, Imperial College London, London W12 0NN, United Kingdom;
Francesco A MauriDepartment of Histopathology, Imperial College London, London W12 0NN, United Kingdom;
Robert J WilkinsonClinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa; Department of Medicine, Imperial College London, London W12 0NN, United Kingdom; Medical Research Council, National Institute for Medical Research, London NW7 1AA, United Kingdom; and.
Jon S FriedlandInfectious Diseases and Immunity, Imperial College London, London W12 0NN, United Kingdom;
Paul T ElkingtonInfectious Diseases and Immunity, Imperial College London, London W12 0NN, United Kingdom; National Institute for Health Research Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom p.elkington@soton.ac.uk.
NIHR Imperial Biomedical Research Centre · GBImperial College London · GBNIHR Southampton Respiratory Biomedical Research Unit · GBSouth African Tuberculosis Vaccine Initiative · ZA

Funding

Targeting matrix metalloproteinases to limit immunopathology in airborne infectioR33AI102239 · NIAID · UNIVERSITY OF SOUTHAMPTON · PI ELKINGTON, PAUL TIMOTHY · 2014 to 2016
$1.1M
Medical Research Council G0900429Medical Research Council U1175.02.002.00014.01NIAID NIH HHS R33 AI102239NIAID NIH HHS R33AI102239Wellcome Trust 084323Wellcome Trust 088316Wellcome Trust 104803
6 · The paper itself

Abstract

Tuberculosis (TB) remains a global pandemic and drug resistance is rising. Multicellular granuloma formation is the pathological hallmark of Mycobacterium tuberculosis infection. The membrane type 1 matrix metalloproteinase (MT1-MMP or MMP-14) is a collagenase that is key in leukocyte migration and collagen destruction. In patients with TB, induced sputum MT1-MMP mRNA levels were increased 5.1-fold compared with matched controls and correlated positively with extent of lung infiltration on chest radiographs (r = 0.483; p < 0.05). M. tuberculosis infection of primary human monocytes increased MT1-MMP surface expression 31.7-fold and gene expression 24.5-fold. M. tuberculosis-infected monocytes degraded collagen matrix in an MT1-MMP-dependent manner, and MT1-MMP neutralization decreased collagen degradation by 73%. In human TB granulomas, MT1-MMP immunoreactivity was observed in macrophages throughout the granuloma. Monocyte-monocyte networks caused a 17.5-fold increase in MT1-MMP surface expression dependent on p38 MAPK and G protein-coupled receptor-dependent signaling. Monocytes migrating toward agarose beads impregnated with conditioned media from M. tuberculosis-infected monocytes expressed MT1-MMP. Neutralization of MT1-MMP activity decreased this M. tuberculosis network-dependent monocyte migration by 44%. Taken together, we demonstrate that MT1-MMP is central to two key elements of TB pathogenesis, causing collagen degradation and regulating monocyte migration.

Indexed as

AdultAgedCell MovementCells, CulturedCollagenCollagenasesFemaleHumansMaleMatrix Metalloproteinase 14Middle AgedMonocytesMycobacterium tuberculosisp38 Mitogen-Activated Protein KinasesRNA, MessengerSputumCollagenCollagenasesMatrix Metalloproteinase 14MMP14 protein, humanp38 Mitogen-Activated Protein KinasesRNA, Messenger

Identifiers

PMID26091717
PMCPMC4505956
OpenAlexW2115754910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.